Skip to menu Skip to content Skip to footer

2019

Conference Publication

Liquid biopsy in cancer—getting down to the nano level. Can nano-diagnostics lead to comprehensive, accurate, and affordable biomarkers to improve advanced breast (ABC) care?

Mainwaring, Paul N., Grewal, Yadveer S., Koo, Kevin M., Anderson, Will and Korbie, Darren J. (2019). Liquid biopsy in cancer—getting down to the nano level. Can nano-diagnostics lead to comprehensive, accurate, and affordable biomarkers to improve advanced breast (ABC) care?. Advanced Breast Cancer Fifth International Consensus Conference (ABC5), Lisbon, Portugal, 14 - 16 November, 2019. London, United Kingdom: Churchill Livingstone. doi: 10.1016/s0960-9776(19)30638-1

Liquid biopsy in cancer—getting down to the nano level. Can nano-diagnostics lead to comprehensive, accurate, and affordable biomarkers to improve advanced breast (ABC) care?

2019

Conference Publication

Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction

Gardiner, F., Koo, K., Wang, J., Richards, R., Farrell, A., Yaxley, J., Samaratunga, H., Teloken, P., Roberts, M., Coughlin, G., Lavin, M., Mainwaring, P., Wang, Y., Gardiner, R. and Trau, M. (2019). Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction. Annual Scientific Meeting of the Urological Society of Australia and New-Zealand, Brisbane, QLD Australia, 13-16 April 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction

2016

Conference Publication

Towards precision medicine: A cancer molecular subtyping nano-strategy for RNA biomarkers in tumor and urine

Koo, K., Wee, E., Mainwaring, P., Wang, Y. and Trau, M. (2016). Towards precision medicine: A cancer molecular subtyping nano-strategy for RNA biomarkers in tumor and urine. 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Munich Germany, November 29 - December 2 2016. United Kingdom: Pergamon. doi: 10.1016/S0959-8049(16)32680-6

Towards precision medicine: A cancer molecular subtyping nano-strategy for RNA biomarkers in tumor and urine

2015

Conference Publication

Towards rapid and cost-effective point-of-care detection of TMPRSS2:ERG fusion transcripts in urine via a novel methodology

Wee, Eugene J.H., Koo, Kevin M., Mainwaring, Paul N. and Trau, Mattias (2015). Towards rapid and cost-effective point-of-care detection of TMPRSS2:ERG fusion transcripts in urine via a novel methodology. 2015 ASCO Annual Meeting, Chicago, IL United States, 29 May - 2 June 2015. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2015.33.15_suppl.11063

Towards rapid and cost-effective point-of-care detection of TMPRSS2:ERG fusion transcripts in urine via a novel methodology

2015

Conference Publication

Towards rapid and cost-effective point-of-care detection of TMPRSS2:ERG fusion transcripts in urine via a novel methodology

Wee, Eugene J. H., Koo, Kevin M., Mainwaring, Paul N. and Trau, Mattias (2015). Towards rapid and cost-effective point-of-care detection of TMPRSS2:ERG fusion transcripts in urine via a novel methodology. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL United States, 29 May-02 June 2015. Alexandria, VA United States: American Society of Clinical Oncology.

Towards rapid and cost-effective point-of-care detection of TMPRSS2:ERG fusion transcripts in urine via a novel methodology